Literature DB >> 2185224

Purification and characterization of a protease from Clostridium botulinum type A that nicks single-chain type A botulinum neurotoxin into the di-chain form.

M L Dekleva1, B R Dasgupta.   

Abstract

A protease that nicks the approximately 150-kilodalton (kDa) single-chain type A botulinum neurotoxin into the approximately 150-kDa di-chain form in vitro was isolated from Clostridium botulinum type A (Hall strain) cultures. The di-chain neurotoxin generated in vitro is composed of an approximately 50-kDa light chain and an approximately 100-kDa heavy chain which are disulfide linked and is indistinguishable from the di-chain neurotoxin that forms in vivo and is routinely isolated (M.L. Dekleva and B.R. DasGupta, Biochem. Biophys. Res. Commun. 162:767-772, 1989). This enzyme was purified greater than 1,000-fold by ammonium sulfate precipitation, QAE-Sephadex Q-50, Sephadex G-100, and CM-Sephadex C-50 chromatography steps with the synthetic substrate N-benzoyl-DL-arginine-p-nitroanilide. The approximately 62-kDa amidase (protease) is a complex of 15.5- and 48-kDa polypeptides (determined by polyacrylamide gel electrophoresis) that could not be separated without sodium dodecyl sulfate. The enzyme has an isoelectric point of pH 5.73, a pH optimum of 6.2 to 6.4, an absolute requirement for a thiol-reducing agent as well as a divalent metallic cation (probably Ca2+) for activity, and a temperature optimum of 70 degrees C. Tests with several synthetic substrates indicated the high specificity of the enzyme for arginyl amide bonds.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2185224      PMCID: PMC208889          DOI: 10.1128/jb.172.5.2498-2503.1990

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  19 in total

1.  Responses of Clostridium botulinum type B and E progenitor toxins to some clostridial sulfhydryl-dependent proteases.

Authors:  I Oishi; T Okada; G Sakaguchi
Journal:  Jpn J Med Sci Biol       Date:  1975-06

2.  A modified spectrophotometric determination of chymotrypsin, trypsin, and thrombin.

Authors:  B C HUMMEL
Journal:  Can J Biochem Physiol       Date:  1959-12

3.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

4.  Response of type B and E Botulinum toxins to purified sulfhydryl-dependent protease produced by Clostridium botulinum type F.

Authors:  I Ohishi; G Sakaguchi
Journal:  Jpn J Med Sci Biol       Date:  1977-08

5.  Isolation and characterization of a protease from Clostridium botulinum type B.

Authors:  B R Dasgupta; H Sugiyama
Journal:  Biochim Biophys Acta       Date:  1972-06-16

6.  Purification and properties of clostridiopeptidase B (Clostripain).

Authors:  W M Mitchell; W F Harrington
Journal:  J Biol Chem       Date:  1968-09-25       Impact factor: 5.157

7.  High-performance liquid chromatography of proteins.

Authors:  F E Regnier
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

Review 8.  Clostridium botulinum toxins.

Authors:  G Sakaguchi
Journal:  Pharmacol Ther       Date:  1982       Impact factor: 12.310

9.  Nature of intracellular type A botulinum neurotoxin.

Authors:  E P Krysinski; H Sugiyama
Journal:  Appl Environ Microbiol       Date:  1981-03       Impact factor: 4.792

10.  Isolation and characterization of an esterase-active enzyme from pronase with special reference to activation of Clostridium botulinum type E progenitor toxin.

Authors:  T Miura
Journal:  Jpn J Med Sci Biol       Date:  1974-12
View more
  8 in total

1.  Novel Native and Engineered Botulinum Neurotoxins.

Authors:  Lance Steward; Mitchell F Brin; Amy Brideau-Andersen
Journal:  Handb Exp Pharmacol       Date:  2021

Review 2.  Proteolytic activation of bacterial toxins: role of bacterial and host cell proteases.

Authors:  V M Gordon; S H Leppla
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

3.  Characterization of an endoserine protease secreted by Arthrobacter aureus.

Authors:  V Michotey; C Blanco
Journal:  Appl Environ Microbiol       Date:  1994-01       Impact factor: 4.792

4.  Regulation of Botulinum Neurotoxin Synthesis and Toxin Complex Formation by Arginine and Glucose in Clostridium botulinum ATCC 3502.

Authors:  Chase M Fredrick; Guangyun Lin; Eric A Johnson
Journal:  Appl Environ Microbiol       Date:  2017-06-16       Impact factor: 4.792

5.  Purification and Characterization of Recombinant Botulinum Neurotoxin Serotype FA, Also Known as Serotype H.

Authors:  Gavin Hackett; Kevin Moore; David Burgin; Fraser Hornby; Bryony Gray; Mark Elliott; Imran Mir; Matthew Beard
Journal:  Toxins (Basel)       Date:  2018-05-11       Impact factor: 4.546

6.  Subunit stoichiometry of the Clostridium botulinum type A neurotoxin complex determined using denaturing capillary electrophoresis.

Authors:  Michael A Lietzow; Elizabeth T Gielow; Denise Le; Jifeng Zhang; Marc F Verhagen
Journal:  Protein J       Date:  2008-12       Impact factor: 2.371

7.  Genome sequence of a proteolytic (Group I) Clostridium botulinum strain Hall A and comparative analysis of the clostridial genomes.

Authors:  Mohammed Sebaihia; Michael W Peck; Nigel P Minton; Nicholas R Thomson; Matthew T G Holden; Wilfrid J Mitchell; Andrew T Carter; Stephen D Bentley; David R Mason; Lisa Crossman; Catherine J Paul; Alasdair Ivens; Marjon H J Wells-Bennik; Ian J Davis; Ana M Cerdeño-Tárraga; Carol Churcher; Michael A Quail; Tracey Chillingworth; Theresa Feltwell; Audrey Fraser; Ian Goodhead; Zahra Hance; Kay Jagels; Natasha Larke; Mark Maddison; Sharon Moule; Karen Mungall; Halina Norbertczak; Ester Rabbinowitsch; Mandy Sanders; Mark Simmonds; Brian White; Sally Whithead; Julian Parkhill
Journal:  Genome Res       Date:  2007-05-22       Impact factor: 9.043

Review 8.  Variations in the Botulinum Neurotoxin Binding Domain and the Potential for Novel Therapeutics.

Authors:  Jonathan R Davies; Sai Man Liu; K Ravi Acharya
Journal:  Toxins (Basel)       Date:  2018-10-20       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.